about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesThe Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic CancerRegulation of inflammation in cancer by eicosanoidsMultiple roles of toll-like receptor 4 in colorectal cancerSmooth muscle tension induces invasive remodeling of the zebrafish intestineCurrent understanding concerning intestinal stem cellsPerspectives on pulmonary inflammation and lung cancer risk in cigarette smokersThe evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!Chemoprevention for colon cancer: new opportunities, fact or fiction?EET signaling in cancerEffects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in miceTGF-beta: a mobile purveyor of immune privilegeNF-kappaB and IKK as therapeutic targets in cancerNickel-induced down-regulation of ΔNp63 and its role in the proliferation of keratinocytesIL-17 mediated inflammation promotes tumor growth and progression in the skinRegulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88The inflammasome NLRs in immunity, inflammation, and associated diseasesThe roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.A D-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization.The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury.Colorectal cancer and NF-κB signaling pathwayCux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis.Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer.Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.Diet components can suppress inflammation and reduce cancer risk.Serum biomarkers which correlate with failure to respond to immunotherapy and tumor progression in a murine colorectal cancer model.xCT deficiency accelerates chemically induced tumorigenesis.Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges.A tissue-specific landscape of sense/antisense transcription in the mouse intestineConvergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.Conditional ablation of Ikkb inhibits melanoma tumor development in mice.Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis.Immune cells: plastic players along colorectal cancer progressionTLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancerThe TIR Domain Containing Locus of Enterococcus faecalis Is Predominant among Urinary Tract Infection Isolates and Downregulates Host Inflammatory Response.Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease.Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells.Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection.
P2860
Q21296830-FEE3B0F5-2347-497C-A21C-E3074F74F662Q21342813-C68C86F6-37A1-42EC-9FC2-7B83F63A5723Q24564308-F85ECFBD-463B-4CFD-9431-63E4DEBF5026Q27008380-755290CB-C1B7-4A71-914D-D494842C6130Q27318726-6E087994-B67F-4FED-A68A-403AA591315EQ27694486-2CEA958B-4E73-49B3-9182-70FA82225DC6Q28199730-4556C13E-35CE-43DE-97A8-C31BEF385518Q28218616-EBBE6714-E2CB-4279-9127-CA90186CF5BCQ28219247-C7294F59-7C8F-4738-B927-84127F8E06C6Q28250730-177EDC95-9F90-41BC-9DC3-6A72071B0F04Q28263562-97E6E80C-8A00-4353-AF90-D48BA399A7DCQ28263622-8FD51B05-862B-4F05-96EE-B23202DDECCEQ28297985-9813AC58-4BC7-43B3-B889-45BEB2B6AF63Q28389269-2CFA5733-37E0-465D-9197-82C8E677DBDAQ28480915-B2A6AEFE-BEC0-405C-8CF3-6529CD253285Q28512135-D7394A50-8B2F-4303-9176-F074EE7B6A61Q29616025-297CAF78-34CE-482F-8041-0AE0E190DEB1Q30235880-C0E40E05-80DC-4D84-AAFC-C612638149AFQ30742270-7D944AE9-ED60-4C9C-8AE0-2978E05F7F38Q33428592-4BEE857B-11FC-40A2-9179-4E74F35F1800Q33596306-C20DD123-39A9-430E-9310-1E6E2C0B77F1Q33694518-60BFC6F2-B689-4C31-A7A1-C2A5D1AC965CQ33707487-B516E946-BF3F-4139-A0E3-0B9E7060B1A9Q33755300-C57A9F03-15F9-49B5-B520-CBDCAD126A20Q33758929-48458F37-CCE3-4B94-B7B0-C81E3E970F6BQ33764534-1B3B71A1-C2F9-407B-B793-95B2D279216EQ33779032-D8FACA5F-B85A-42A2-B7BF-805C722DC209Q33891519-71685688-BE2D-49B8-B646-C0B5CD107852Q33929606-ECDC6E6E-2407-428B-8CDE-4E038551DE67Q33954537-730D56BC-35BF-4B17-9848-ED1B08B99CA0Q33964919-A28C7C21-5EFE-45DE-9474-A9B220B61DB2Q33968131-51EBE3E6-B2C0-49FE-A514-CF5D08493123Q33976435-BC66C109-07AD-465D-BBCE-84E253F5DB39Q33985586-0AA0F3F2-492E-4D24-BB7A-3B1349E61D8BQ34000194-0AEA3797-FE76-49AE-A9F3-D6F4F303BF48Q34000467-F59AEA25-C1EB-4134-8720-DB9155EFDD9BQ34039552-15F95F98-B647-4B76-B4D3-05882A97C988Q34053718-3EA4CDEA-7734-444D-A811-10B1AFE554E2Q34067493-E981A612-6796-402B-8EB1-213CA35541AFQ34093629-C3E5F436-1AB5-4D5D-A565-59F320DEFF53
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
At the crossroads of inflammation and cancer.
@ast
At the crossroads of inflammation and cancer.
@en
type
label
At the crossroads of inflammation and cancer.
@ast
At the crossroads of inflammation and cancer.
@en
prefLabel
At the crossroads of inflammation and cancer.
@ast
At the crossroads of inflammation and cancer.
@en
P1433
P1476
At the crossroads of inflammation and cancer.
@en
P2093
Hans Clevers
P304
P356
10.1016/J.CELL.2004.09.005
P407
P577
2004-09-01T00:00:00Z